journal article·2026-01Open access

Self‐Trapped Excitons in Carbon Quantum Dots with Large NIR‐II Photo‐Thermoelectric Catalysis Induce Pyroptosis for Cancer Therapy

Tesen Zhang, Qingcheng Wang, Quansheng Cheng, Han Wang, He Feng, Hui Zhang, Mengbo Lin, Feili Cai, Zheng Fang, Ruo Wang, Gang Chen

Advanced Science· Volume 13· Issue 4

Abstract

Abstract Pyroptosis, an immunogenic cell death mechanism triggered by Gasdermin family proteins, represents a transformative frontier in tumor immunotherapy. While carbon quantum dots (CQDs) have emerged as pyroptosis‐triggering agents, their efficacy in NIR‐II light‐mediated therapy remains constrained by a low absorption coefficient and uncontrolled charge recombination. Herein, CQDs with high‐density self‐trapped excitons (STEs) exhibiting NIR‐II absorption and an exceptional photothermal conversion efficiency of 51.2% are engineered. By optimizing the migration dynamics of hot carriers, directional charge separation is achieved, which generates cytotoxic hydroxyl radicals and superoxide radicals. The synergistic photo‐thermoelectric catalysis triggers pyroptosis via reactive oxygen species‐caspase 1‐gasdermin D activation, eliciting robust systemic immunity that effectively eliminates the primary tumor and prevents tumor recurrence. This work establishes STE engineering as a universal design principle for advanced nanomaterials while pioneering a NIR‐II‐responsive pyroptosis platform that bridges localized ablation with systemic antitumor immunity, offering a paradigm shift for precision immuno‐oncology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Carbon and Quantum Dots Applications · Heme Oxygenase-1 and Carbon Monoxide

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Interdisciplinary Institute of Medical Engineering Fuzhou University Fuzhou 350108 China

Institute of Applied Physics and Materials Engineering University of Macau Macau SAR 999078 China

Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Shengli Clinical Medical College of Fujian Medical University, Department of Breast Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital Fuzhou University Fuzhou 350001 China

Institute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Shengli Clinical Medical College of Fujian Medical University, Department of Endocrinology, Fujian Provincial Hospital Fuzhou University Affiliated Provincial Hospital Fuzhou 350001 China

Funding

National Natural Science Foundation of China

References (44)

Show source-provided references
1. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
2. 10.1038/s44222-023-00022-y10.1038/s44222-023-00022-y ↗
3. 10.1038/s44222-024-00257-310.1038/s44222-024-00257-3 ↗
4. 10.1002/smll.20230542610.1002/smll.202305426 ↗
5. 10.1038/s41565-022-01189-y10.1038/s41565-022-01189-y ↗
6. 10.1038/nm.339410.1038/nm.3394 ↗
7. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
8. 10.1039/D4CS00679H10.1039/D4CS00679H ↗
9. 10.1038/s41565-022-01125-010.1038/s41565-022-01125-0 ↗
10. 10.3390/cells1109141510.3390/cells11091415 ↗
11. 10.1016/S0966-842X(00)01936-310.1016/S0966-842X(00)01936-3 ↗
12. 10.1021/acs.nanolett.3c0272810.1021/acs.nanolett.3c02728 ↗
13. 10.1038/s41580-025-00837-010.1038/s41580-025-00837-0 ↗
14. 10.1021/jacs.2c0325610.1021/jacs.2c03256 ↗
15. 10.1038/s41577-019-0228-210.1038/s41577-019-0228-2 ↗
16. 10.1038/s41422-025-01107-610.1038/s41422-025-01107-6 ↗
17. 10.1038/nature1859010.1038/nature18590 ↗
18. 10.1038/nature1551410.1038/nature15514 ↗
19. 10.1186/s12943-024-02183-910.1186/s12943-024-02183-9 ↗
20. 10.1002/adma.20250039910.1002/adma.202500399 ↗
21. 10.1016/j.bcp.2020.11402310.1016/j.bcp.2020.114023 ↗
22. 10.1038/nature2239310.1038/nature22393 ↗
23. 10.1002/adfm.20250578410.1002/adfm.202505784 ↗
24. 10.1016/j.nantod.2023.10209110.1016/j.nantod.2023.102091 ↗
25. 10.1002/anie.20201639910.1002/anie.202016399 ↗
26. 10.1002/adma.20220881710.1002/adma.202208817 ↗
27. 10.1002/adfm.20221342510.1002/adfm.202213425 ↗
28. 10.1002/ange.20241789910.1002/ange.202417899 ↗
29. 10.1073/pnas.241035712110.1073/pnas.2410357121 ↗
30. 10.1021/acscentsci.3c0129610.1021/acscentsci.3c01296 ↗
31. 10.1016/j.matt.2021.10.01610.1016/j.matt.2021.10.016 ↗
32. 10.1039/D3QM00043E10.1039/D3QM00043E ↗
33. 10.1126/sciadv.adn789610.1126/sciadv.adn7896 ↗
34. 10.1002/adfm.20240297610.1002/adfm.202402976 ↗
35. Zhang H. Q. · Respons. Mater. · 2024 · 2
36. 10.1038/s41586-024-08358-010.1038/s41586-024-08358-0 ↗
37. 10.1002/adfm.20241868310.1002/adfm.202418683 ↗
38. 10.1021/acs.nanolett.4c0391310.1021/acs.nanolett.4c03913 ↗
39. 10.1002/adma.20240868510.1002/adma.202408685 ↗
40. 10.1002/adma.20230270510.1002/adma.202302705 ↗
41. 10.1021/jacs.3c1329610.1021/jacs.3c13296 ↗
42. Song Y. L. · Adv. Healthcare Mater. · 2019 · 33
43. 10.1038/s41377-024-01673-110.1038/s41377-024-01673-1 ↗
44. 10.1038/s41377-025-01757-610.1038/s41377-025-01757-6 ↗